Comparison of topical tretinoin versus topical tazarotene in acne vulgaris.
Not Applicable
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/11/060308
- Lead Sponsor
- Department of Dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of acne vulgaris (Grade 1 & 2) involving face and not requiring systemic therapy.
2. Patients of 18-50 years of age.
Exclusion Criteria
1. Pregnant and lactating mothers
2. Patients having any systemic illness requiring drugs
3. Patients with signs and symptoms of hyperandrogenism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method